European Pharmaceutical Pricing and Reimbursement Conference 2015
October 5 - 6, 2015
london , United Kingdom
SMi's 21st annual European Pharmaceutical Pricing & Reimbursement conference, taking place on 5-6 October 2015 in London, will bring together senior industry figures from big pharma, biotech and academia discussing recent updates and highlighting strategies to deal with the latest P&R developments through keynote addresses, case studies and roundtable discussions. International changes in policy will also be highlighted, along with an in-depth focus on biosimilar dugs and the impact that they have had on P&R through nations across Europe.
Benefits of attending:
- Evaluate new models for European reimbursement
- Develop understanding of tiered pricing options with case studies from GSK
- Gain further insight into current HTA policies
- Receive invaluable information from field leaders through in-depth case studies
- Learn about changes in UK P&R policy following the UK elections from industry bodies EMIG and the ABPI
Speaker Panel includes:
- Leslie Galloway, Chairman, Ethical Medicines Industry Group
- Alexander Natz, Secretary General, European Confederation of Pharmaceutical Entrepreneurs
- Janice Haigh, Practice Leader Market Access, Quintiles
- Ken Walsh, Head Emerging Markets Pricing, GSK
- Toros Sahin, Head of Market Access & Health Economics, Sanofi Turkey
- David Watson, Director of Pricing & Reimbursement, ABPI
- Alexander Roediger, Director European Union Affairs, MSD
- Leyla Hannbeck, Head of Pharmacy, National Pharmaceutical Association Ltd
- Eric Low, CEO, Myeloma UK
The conference will also feature an interactive post-conference workshop on: HTA Uncovered, led by Anke Van Engen, Chief Development Officer and Janice Haigh, Practice Leader Market Access, Quintiles, taking place on the 7th October 2015 in London.
Benefits of attending:
- Evaluate new models for European reimbursement
- Develop understanding of tiered pricing options with case studies from GSK
- Gain further insight into current HTA policies
- Receive invaluable information from field leaders through in-depth case studies
- Learn about changes in UK P&R policy following the UK elections from industry bodies EMIG and the ABPI
Speaker Panel includes:
- Leslie Galloway, Chairman, Ethical Medicines Industry Group
- Alexander Natz, Secretary General, European Confederation of Pharmaceutical Entrepreneurs
- Janice Haigh, Practice Leader Market Access, Quintiles
- Ken Walsh, Head Emerging Markets Pricing, GSK
- Toros Sahin, Head of Market Access & Health Economics, Sanofi Turkey
- David Watson, Director of Pricing & Reimbursement, ABPI
- Alexander Roediger, Director European Union Affairs, MSD
- Leyla Hannbeck, Head of Pharmacy, National Pharmaceutical Association Ltd
- Eric Low, CEO, Myeloma UK
The conference will also feature an interactive post-conference workshop on: HTA Uncovered, led by Anke Van Engen, Chief Development Officer and Janice Haigh, Practice Leader Market Access, Quintiles, taking place on the 7th October 2015 in London.
Organizer
SMi Group Ltd
2nd Floor South, Harling House
47-51 Great Suffolk Street
London
SE1 0BS
United Kingdom
+44 (0) 20 7827 6000
Related events
European Pharmaceutical Pricing and Reimbursement Conference October 5 - 6, 2015
European Pharmaceutical Pricing and Reimbursement Conference October 13 - 14, 2014
European Pharmaceutical Pricing and Reimbursement Conference October 29 - 30, 2012
European Pharmaceutical Pricing and Reimbursement Conference October 31 - November 1, 2011
European Pharmaceutical Pricing and Reimbursement Conference October 27 - 28, 2010